Healthcare Infection Control Practices Advisory Committee (HICPAC), 14855 [2018-07050]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health. The Board of
Scientific Counselors provides guidance
to the Director, National Institute for
Occupational Safety and Health on
research and prevention programs.
Specifically, the Board provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and
disseminating results. The Board
evaluates the degree to which the
activities of the National Institute for
Occupational Safety and Health: (1)
Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters To Be Considered: The agenda
for the meeting addresses occupational
safety and health issues related to: (1)
Use of contribution analysis to evaluate
research impact; (2) breach in the
protective barrier system of the glove
and gown interface; (3) occupational
safety and health workforce training;
and (4) safe-skilled-ready workforce
update—Research for Young and
Temporary Workers.
Agenda items are subject to change as
priorities dictate. An agenda is also
posted on the NIOSH website (https://
www.cdc.gov/niosh/bsc/). Members of
the public who wish to address the
NIOSH BSC are requested to contact the
Executive Secretary for scheduling
purposes (see contact information
below). Alternatively, written comments
to the BSC may be submitted via an online form at the following website:
https://www.cdc.gov/niosh/bsc/
contact.html. Agenda items are subject
to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07049 Filed 4–5–18; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
19:21 Apr 05, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. Attendance is limited only
by room seating available, (add number
of seats that will be available in the
room). The public is also welcome to
listen to the meeting via teleconference;
100 teleconference lines are available.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt of written public
comment is May 3, 2018. All requests
must contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length
and delivered in 3 minutes or less.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. Registration is required to
attend in person or on the phone.
Interested parties may register at
www.cdc.gov/hicpac.
DATES: The meeting will be held on May
17, 2018, 9:00 a.m. to 5:00 p.m., EDT,
and May 18, 2018, 9:00 a.m. to 12:00
p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia 30329
and teleconference at 866–692–3582,
passcode: 66783078.
FOR FURTHER INFORMATION CONTACT: Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
SUMMARY:
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
14855
CDC, 1600 Clifton Road NE, Mailstop
A–07, Atlanta, Georgia 30329,
Telephone (404) 639–4045. Email
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup; the National Healthcare
Safety Network (NHSN) Workgroup; the
Neonatal Intensive Care Unit (NICU)
Guideline Workgroup; and the Products
and Practices Workgroup. Agenda items
are subject to change as priorities
dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07050 Filed 4–5–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Immunization Practices
(ACIP).
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
SUMMARY:
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 83, Number 67 (Friday, April 6, 2018)]
[Notices]
[Page 14855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07050]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public; however, visitors must be processed in accordance with
established federal policies and procedures. Attendance is limited only
by room seating available, (add number of seats that will be available
in the room). The public is also welcome to listen to the meeting via
teleconference; 100 teleconference lines are available. Time will be
available for public comment. The public is welcome to submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed below. The deadline for
receipt of written public comment is May 3, 2018. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length and delivered in 3
minutes or less. Members of the public who wish to provide public
comments should plan to attend the public comment session at the start
time listed. Please note that the public comment period may end before
the time indicated, following the last call for comments. Written
comments received in advance of the meeting will be included in the
official record of the meeting. Registration is required to attend in
person or on the phone. Interested parties may register at www.cdc.gov/hicpac.
DATES: The meeting will be held on May 17, 2018, 9:00 a.m. to 5:00
p.m., EDT, and May 18, 2018, 9:00 a.m. to 12:00 p.m., EDT.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE,
Atlanta, Georgia 30329 and teleconference at 866-692-3582, passcode:
66783078.
FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE,
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045. Email
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: The
Healthcare Personnel Guideline Workgroup; the National Healthcare
Safety Network (NHSN) Workgroup; the Neonatal Intensive Care Unit
(NICU) Guideline Workgroup; and the Products and Practices Workgroup.
Agenda items are subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-07050 Filed 4-5-18; 8:45 am]
BILLING CODE 4163-19-P
